Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,321.80 +14.58 0.10%
S&P 500 1,650.01 -5.34 -0.32%
Nasdaq 3,463.61 +0.31 0.01%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Atrion Corp

+ Add to Watchlist

ATRI:US

210.0000 USD 1.0500 0.50%

As of 11:43:41 ET on 05/23/2013.

Company Profile for Atrion Corp (ATRI)

Atrion Corporation, through its subsidiaries, designs, develops, manufactures, markets, sells, and distributes medical products and components. The Company's products are used in ophthalmic, diagnostic, and cardiovascular procedures. Atrion's products are sold primarily to health care companies which market and distribute its products in conjunction with their name-brand products.

Contact Information

Atrion Corp

One Allentown Parkway
Allen, TX 75002-4211
United States
Phone: 1-972-390-9800
Fax: 1-972-396-7581

Key Executives for Atrion Corp (ATRI)

David A BattatPresident/CEOJeffery StricklandVP/CFO/Treasurer/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil